These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 36615513)

  • 1. Repurposed Drugs in Gastric Cancer.
    Araújo D; Ribeiro E; Amorim I; Vale N
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond.
    Choi AH; Kim J; Chao J
    World J Gastroenterol; 2015 Jun; 21(24):7343-8. PubMed ID: 26139980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of adjuvant and neoadjuvant therapy for resectable gastric cancer in the East.
    Fujitani K
    Dig Surg; 2013; 30(2):119-29. PubMed ID: 23867588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
    Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
    BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.
    Miceli R; Tomasello G; Bregni G; Di Bartolomeo M; Pietrantonio F
    World J Gastroenterol; 2014 Apr; 20(16):4516-25. PubMed ID: 24782604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status and prospect of perioperative therapy for locally advanced gastric cancer].
    Zhu ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):101-106. PubMed ID: 33508913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 8. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
    Cheng X; Wu D; Xu N; Chen L; Yan Z; Chen P; Zhou L; Yu J; Cui J; Li W; Wang C; Feng W; Wei Y; Yu P; Du Y; Ying J; Xu Z; Yang L; Zhang Y
    BMC Cancer; 2021 Jan; 21(1):56. PubMed ID: 33435909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastric cancer: (neo-)adjuvant treatment].
    Fischbach W
    Dtsch Med Wochenschr; 2012 Sep; 137(37):1822-4. PubMed ID: 22956228
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy in gastric cancer.
    Wöll E; Devries A; Eisterer W; Hejna M; Keil F; Stein H; Zacherl J; Greil R
    Anticancer Res; 2008; 28(2B):1213-9. PubMed ID: 18505058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What make differences in the outcome of adjuvant treatments for resected gastric cancer?
    Nakajima T; Fujii M
    World J Gastroenterol; 2014 Sep; 20(33):11567-73. PubMed ID: 25206264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer].
    Zhao Q; Li Y; Tan BB; Tian Y; Jiao ZK; Zhao XF; Zhang ZD; Wang D; Yang PG
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):773-7. PubMed ID: 24378101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
    Rosen H
    Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Conversion therapy of advanced gastric cancer].
    Cheng X; Mao Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1127-1130. PubMed ID: 29130225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy.
    Coccolini F; Fugazzola P; Ansaloni L; Sartelli M; Cicuttin E; Leandro G; De' Angelis GL; Gaiani F; Di Mario F; Tomasoni M; Catena F
    Acta Biomed; 2018 Dec; 89(8-S):104-109. PubMed ID: 30561427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thinking of the application of membrane anatomy in gastric cancer surgery after neoadjuvant therapy].
    Zhao DB; Zhang XJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(7):657-660. PubMed ID: 32683826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-adjuvant chemotherapy leukocyte count may predict the outcome for advanced gastric cancer after radical resection.
    Pei D; Zhu F; Chen X; Qian J; He S; Qian Y; Shen H; Liu Y; Xu J; Shu Y
    Biomed Pharmacother; 2014 Mar; 68(2):213-7. PubMed ID: 24581723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer.
    Slagter AE; Jansen EPM; van Laarhoven HWM; van Sandick JW; van Grieken NCT; Sikorska K; Cats A; Muller-Timmermans P; Hulshof MCCM; Boot H; Los M; Beerepoot LV; Peters FPJ; Hospers GAP; van Etten B; Hartgrink HH; van Berge Henegouwen MI; Nieuwenhuijzen GAP; van Hillegersberg R; van der Peet DL; Grabsch HI; Verheij M
    BMC Cancer; 2018 Sep; 18(1):877. PubMed ID: 30200910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of chemotherapy in the current treatment of gastric cancer.
    Van Cutsem E; Haller D; Ohtsu A
    Gastric Cancer; 2002; 5 Suppl 1():17-22. PubMed ID: 12772882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.